Research and development Driving scientific innovation to deliver the next generation of transformational medicines and vaccines for patients
Read morePress releases
- World’s first meningitis B national infant vaccination programme shows 75% drop in cases over three years
- US Food and Drug Administration (FDA) grants priority review of belantamab mafodotin for patients with relapsed or refractory multiple myeloma
- Dovato (dolutegravir/lamivudine), the once-daily, single-pill, 2-drug regimen for the treatment of HIV-1 infection, granted marketing approval by Japan Ministry of Health, Labour and Welfare
Tweets from GSK
-
GSK @GSK
Go #BehindtheScience to discover how the complex roles of the microorganisms living in our lungs are informing advances in #respiratory medicine. #COPD #asthma
about 9 hours ago -
GSK @GSK
We're at #WEF20. For 20 years we’ve proudly supported @gavi in their mission to improve access to vaccines for millions of the most vulnerable children. We wish them a happy 20th anniversary! #VaccinesWork
about 1 day ago
-
GSK @GSK
You may have heard of the gut microbiome, but do you know what the lung microbiome is and why it’s important in better understanding and potentially treating #respiratory disease? #COPD #asthma
about 1 day ago
